Wet AMD market.
Basharut A
BA
Syed
James B
JB
Evans
Leonard
L
Bielory
D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D017277:Drug Approval; D015195:Drug Design; D006801:Humans; D010778:Photochemotherapy / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D057135:Wet Macular Degeneration / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology
D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A